Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rapid and Cost-Efficient Detection of RET Rearrangements in a Large Consecutive Series of Lung Carcinomas.
Tiurin VI, Preobrazhenskaya EV, Mitiushkina NV, Romanko AA, Anuskina AA, Mulkidjan RS, Saitova ES, Krivosheyeva EA, Kharitonova ED, Shevyakov MP, Tryakin IA, Aleksakhina SN, Venina AR, Sokolova TN, Martianov AS, Shestakova AD, Ivantsov AO, Iyevleva AG, Imyanitov EN. Tiurin VI, et al. Among authors: sokolova tn. Int J Mol Sci. 2023 Jun 23;24(13):10530. doi: 10.3390/ijms241310530. Int J Mol Sci. 2023. PMID: 37445709 Free PMC article.
Untranslated Region Sequences and the Efficacy of mRNA Vaccines against Tuberculosis.
Reshetnikov V, Terenin I, Shepelkova G, Yeremeev V, Kolmykov S, Nagornykh M, Kolosova E, Sokolova T, Zaborova O, Kukushkin I, Kazakova A, Kunyk D, Kirshina A, Vasileva O, Seregina K, Pateev I, Kolpakov F, Ivanov R. Reshetnikov V, et al. Int J Mol Sci. 2024 Jan 10;25(2):888. doi: 10.3390/ijms25020888. Int J Mol Sci. 2024. PMID: 38255961 Free PMC article.
Strong founder effect for BRCA1 c.3629_3630delAG pathogenic variant in Chechen patients with breast or ovarian cancer.
Sokolenko AP, Sultanova LV, Stepanov IA, Romanko AA, Venina AR, Sokolova TN, Musayeva HS, Tovgereeva MY, Magomedova MK, Akhmatkhanov KU, Vagapova EI, Suleymanov EA, Vasilyeva EV, Bakaeva EK, Bizin IV, Aleksakhina SN, Imyanitov EN. Sokolenko AP, et al. Among authors: sokolova tn. Cancer Med. 2023 Feb;12(3):3167-3171. doi: 10.1002/cam4.5159. Epub 2022 Aug 23. Cancer Med. 2023. PMID: 36000185 Free PMC article.
Comprehensive evaluation of the test for 5'-/3'-end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer.
Mitiushkina NV, Romanko AA, Preobrazhenskaya EV, Tiurin VI, Ermachenkova TI, Martianov AS, Mulkidjan RS, Sokolova TN, Kholmatov MM, Bizin IV, Ivantsov AO, Yatsuk OS, Zaitseva OA, Iyevleva AG, Kuligina ES, Imyanitov EN. Mitiushkina NV, et al. Among authors: sokolova tn. Cancer Med. 2022 Sep;11(17):3226-3237. doi: 10.1002/cam4.4686. Epub 2022 Mar 23. Cancer Med. 2022. PMID: 35322575 Free PMC article.
Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer.
Moiseyenko FV, Kuligina ES, Zhabina AS, Belukhin SA, Laidus TA, Martianov AS, Zagorodnev KA, Sokolova TN, Chuinyshena SA, Kholmatov MM, Artemieva EV, Stepanova EO, Shuginova TN, Volkov NM, Yanus GA, Imyanitov EN. Moiseyenko FV, et al. Among authors: sokolova tn. Int J Clin Oncol. 2022 May;27(5):850-862. doi: 10.1007/s10147-022-02128-6. Epub 2022 Feb 16. Int J Clin Oncol. 2022. PMID: 35171360 Free PMC article.
Content of circulating tumor DNA depends on the tumor type and the dynamics of tumor size, but is not influenced significantly by physical exercise, time of the day or recent meal.
Kuligina ES, Meerovich R, Zagorodnev KA, Kholmatov MM, Sokolova TN, Laidus TA, Romanko AA, Martianov AS, Anisimova MO, Zaitseva OA, Yatsuk OS, Yanus GA, Imyanitov EN. Kuligina ES, et al. Among authors: sokolova tn. Cancer Genet. 2021 Aug;256-257:165-178. doi: 10.1016/j.cancergen.2021.05.014. Epub 2021 May 28. Cancer Genet. 2021. PMID: 34186498
Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients.
Sokolenko AP, Gorodnova TV, Bizin IV, Kuligina ES, Kotiv KB, Romanko AA, Ermachenkova TI, Ivantsov AO, Preobrazhenskaya EV, Sokolova TN, Broyde RV, Imyanitov EN. Sokolenko AP, et al. Among authors: sokolova tn. Cancer Chemother Pharmacol. 2021 Sep;88(3):439-450. doi: 10.1007/s00280-021-04301-6. Epub 2021 Jun 2. Cancer Chemother Pharmacol. 2021. PMID: 34080040
Efficacy of lorlatinib in lung carcinomas carrying distinct ALK translocation variants: The results of a single-center study.
Orlov SV, Iyevleva AG, Filippova EA, Lozhkina AM, Odintsova SV, Sokolova TN, Mitiushkina NV, Tiurin VI, Preobrazhenskaya EV, Romanko AA, Martianov AS, Ivantsov AO, Aleksakhina SN, Togo AV, Imyanitov EN. Orlov SV, et al. Among authors: sokolova tn. Transl Oncol. 2021 Aug;14(8):101121. doi: 10.1016/j.tranon.2021.101121. Epub 2021 May 21. Transl Oncol. 2021. PMID: 34030112 Free PMC article.
42 results